The Effectiveness of Blended Forensic Ambulant Systemic Therapy (FASTb): A Randomized Controlled Trial Comparing Blended and Regular FAST

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to investigate whether blended Forensic Ambulant Systemic Therapy (FASTb) is equally effective as regular FAST (FASTr).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 21
Healthy Volunteers: f
View:

• Juvenile has an estimated IQ-score of 80 or higher and/or sufficient adaptive skills to benefit from the intervention. The estimated IQ-score is measured using the Screener voor intelligentie en licht verstandelijke beperking (SCIL). The score on the SCIL determiners whether an IQ-test and/or a measurement of adaptive skills using the ADAPT is necessary;

• Juvenile is aged 12-21 years old at intervention start;

• Juvenile exhibits externalizing behavior that results in problems in at least two areas of life (family, school, leisure time), determined by referrer information and/or intake;

• Juvenile has a medium to high recidivism risk, measured by the Risicotaxatie-instrument voor de Ambulante Forensische GGZ Jeugd (RAF GGZ Jeugd) and/or the Landelijk Instrumentarium Jeugdstrafrechtketen (LIJ);

• Presence of juvenile-caregiver relationship problems, as measured by the RAF GGZ Jeugd;

• Juvenile has a diagnosis of a DSM-5 behavioral disorder, which is determined using case file analysis or a new diagnostic process;

• Caregiver(s) and juvenile cannot be motivated to follow treatment at the outpatient clinic;

• Juvenile and caregiver(s) have sufficient Dutch language skills, as estimated by the FAST therapist team;

• Treatment can be offered in either a voluntary or mandatory framework;

⁃ Juvenile resides with their caregiver(s) or is expected to return to residing with caregiver(s) within the first two months of intervention.

‣ A potential subject who meets any of the following criteria will be excluded from participation in this study:

Locations
Other Locations
Netherlands
de Waag
NOT_YET_RECRUITING
Utrecht
Utrecht University
RECRUITING
Utrecht
Contact Information
Primary
Marjolein van Cappellen
s.m.vancappellen@uu.nl
+31621944124
Backup
Jessica Asscher
j.j.asscher@uu.nl
+31624584734
Time Frame
Start Date: 2022-11-14
Estimated Completion Date: 2028-12
Participants
Target number of participants: 200
Treatments
Experimental: FASTb
Participants receive FAST blended (FASTb): a combination of face-to-face and online therapy
Active_comparator: FASTr
Participants receive FAST regular (FASTr): face-to-face therapy
Sponsors
Leads: Utrecht University
Collaborators: De Waag

This content was sourced from clinicaltrials.gov